ArriVent BioPharma, Inc. Common Stock (AVBP) Ownership

$20.40

$0.23 (-1.12%)
Last update: 04:00 PM EST
Day's range
$19.64
Day's range
$20.7

ArriVent BioPharma, Inc. Common Stock Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
HHLR ADVISORS, LTD. 05/15/2025 4.48 M $82.92 M   0.00% 14.25%
ORBIMED ADVISORS LLC 05/15/2025 3.03 M $55.98 M   0.00% 9.62%
SUVRETTA CAPITAL MANAGEMENT, LLC 05/15/2025 2.34 M $43.22 M   4.07% 6.90%
BLACKROCK, INC. 05/02/2025 2.14 M $39.56 M   0.22% 6.31%
FMR LLC 05/12/2025 2.08 M $38.43 M   -1.07% 6.13%
05/16/2025 2.07 M $38.20 M   25.69% 6.10%
OCTAGON CAPITAL ADVISORS LP 05/16/2025 2.06 M $38.08 M   0.00% 6.08%
NOVO HOLDINGS A/S 05/15/2025 1.87 M $34.62 M   23.12% 5.95%
SOFINNOVA INVESTMENTS, INC. 05/15/2025 1.70 M $31.37 M   0.00% 5.39%
VANGUARD GROUP INC 05/09/2025 1.50 M $27.80 M   6.07% 4.43%
GENERAL CATALYST GROUP MANAGEMENT, LLC 04/16/2025 1.49 M $27.64 M   0.00% 4.41%
STATE STREET CORP 05/15/2025 767.74 K $14.20 M   -5.69% 2.26%
SC CHINA HOLDING LTD 05/13/2025 663.31 K $13.98 M   0.00% 1.96%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 614.52 K $11.37 M   3.08% 1.81%
HIDDEN LAKE ASSET MANAGEMENT LP 05/15/2025 254.37 K $4.70 B   37.79% 0.75%
NORTHERN TRUST CORP 05/13/2025 237.70 K $4.40 M   -1.37% 0.70%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 196.49 K $3.63 M   -4.79% 0.58%
MILLENNIUM MANAGEMENT LLC 05/15/2025 158.06 K $2.92 M   200.81% 0.50%
WOODLINE PARTNERS LP 05/15/2025 146.37 K $2.71 M   0.40% 0.43%
MORGAN STANLEY 05/15/2025 121.94 K $2.25 M   -17.93% 0.36%
GOLDMAN SACHS GROUP INC 05/16/2025 76.88 K $1.42 M   -62.91% 0.23%
BANK OF NEW YORK MELLON CORP 04/29/2025 68.23 K $1.26 M   0.33% 0.20%
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 61.35 K $1.13 M   46.34% 0.18%
05/12/2025 44.28 K $818.78 K   100.00% 0.13%
TWO SIGMA INVESTMENTS, LP 05/15/2025 41.38 K $765.14 K   100.00% 0.12%
BARCLAYS PLC 05/15/2025 40.58 K $751.00 K   -24.14% 0.12%
RHUMBLINE ADVISERS 04/08/2025 37.14 K $686.76 K   1.23% 0.11%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 36.79 K $680.27 K   106.27% 0.11%
MARSHALL WACE, LLP 05/15/2025 35.85 K $662.88 K   100.00% 0.11%
CITIGROUP INC 05/12/2025 34.17 K $631.79 K   0.14% 0.10%
BANK OF AMERICA CORP /DE/ 05/15/2025 29.29 K $541.48 K   -35.70% 0.09%
ALLIANCEBERNSTEIN L.P. 05/15/2025 28.20 K $521.42 K   0.00% 0.08%
SWISS NATIONAL BANK 05/12/2025 26.40 K $488.14 K   0.00% 0.08%
ALPS ADVISORS INC 04/30/2025 25.17 K $465.34 K   -7.65% 0.07%
DEUTSCHE BANK AG\ 05/09/2025 23.18 K $428.65 K   -3.95% 0.07%
SG AMERICAS SECURITIES, LLC 04/15/2025 22.68 K $419.00 K   92.09% 0.07%
EXODUSPOINT CAPITAL MANAGEMENT, LP 05/14/2025 22.27 K $412.00 K   100.00% 0.07%
SQUAREPOINT OPS LLC 05/15/2025 18.43 K $340.70 K   100.00% 0.05%
INTECH INVESTMENT MANAGEMENT LLC 05/20/2025 18.07 K $334.10 K   22.10% 0.05%
TWO SIGMA ADVISERS, LP 05/15/2025 18.00 K $332.82 K   100.00% 0.05%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 05/15/2025 17.55 K $324.80 K   2.52% 0.05%
RAFFERTY ASSET MANAGEMENT, LLC 05/14/2025 17.41 K $321.89 K   -36.23% 0.05%
METLIFE INVESTMENT MANAGEMENT, LLC 05/14/2025 17.11 K $316.36 K   -2.00% 0.05%
TUDOR INVESTMENT CORP ET AL 05/15/2025 15.29 K $282.77 K   100.00% 0.05%
JPMORGAN CHASE & CO 05/12/2025 16.33 K $301.92 K   4.11% 0.05%
INVESCO LTD. 05/12/2025 15.13 K $279.75 K   -1.36% 0.04%
WELLS FARGO & COMPANY/MN 05/13/2025 14.82 K $274.00 K   2.25% 0.04%
DYNAMIC TECHNOLOGY LAB PRIVATE LTD 05/16/2025 14.38 K $266.00 K   100.00% 0.04%
COREBRIDGE FINANCIAL, INC. 05/14/2025 13.80 K $255.22 K   -1.46% 0.04%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 05/15/2025 13.65 K $252.37 K   0.00% 0.04%

ArriVent BioPharma, Inc. Common Stock institutional Ownership - FAQ's

During the previous two years, 89 institutional investors and hedge funds held shares of ArriVent BioPharma, Inc. Common Stock. The most heavily invested institutionals were:

HHLR ADVISORS, LTD.: 4.48 M

ORBIMED ADVISORS LLC: 3.03 M

SUVRETTA CAPITAL MANAGEMENT, LLC: 2.34 M

BlackRock, Inc.: 2.14 M

FMR LLC: 2.08 M

Octagon Capital Advisors LP: 2.06 M

92.42% of ArriVent BioPharma, Inc. Common Stock stock is owned by institutional investors.

Institutional investors have bought a total of 28.02 M shares in the last 24 months. This purchase volume represents approximately $571.53 M in transactions.